Polypharmacy is increasingly prevalent among U.S. adults, highlighting the need for targeted management, especially in older patients and those with cardiovascular or metabolic comorbidities.
From 1999-2000 to 2017-2018, the prevalence of polypharmacy is continually increasing in U.S. adults. The polypharmacy was especially higher in the older, in patients with heart disease, or diabetes. The high prevalence urges the healthcare providers and health policymakers to manage polypharmacy among specific population groups.
Wang et al. (2023) studied this question.